13F filer · CIK 1103804 ↗
Viking Global
You are looking at Q4 2019. See the latest, Q2 2026 →
Reported value
$21.35B
+11% on the quarter before
Positions
66
18 new · 14 sold out
Top 10
50.0%
of the value
Est. gain
+$2.07B
on stocks held all quarter
Est. return
+14.2%
on those stocks since Q3 2019
Positions as of Dec 31, 2019, from Viking Global's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q3 2019. Striped tiles are options.
Largest buys
Since Q3 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Uber~$701.6MAdded · 2.3% → 5.3%+23,591,568 shares
- Boston Scientific Corp~$365.2MAdded · 2.2% → 3.9%+8,075,615 shares
- Metlife Inc~$342.7MNew · 0.0% → 1.6%+6,723,542 shares
- Unitedhealth Group Inc~$281.6MNew · 0.0% → 1.3%+958,037 shares
- ServiceNow~$277.5MAdded · 2.3% → 3.6%+982,871 shares
- Booking Hldgs Inc~$262.2MNew · 0.0% → 1.2%+127,676 shares
- Textron Inc~$220.5MNew · 0.0% → 1.0%+4,944,853 shares
- Mckesson Corp~$208.6MNew · 0.0% → 1.0%+1,508,413 shares
- Activision Blizzard Inc~$193.2MAdded · 0.2% → 1.1%+3,250,679 shares
- Fortive Corp~$177.5MAdded · 1.7% → 2.6%+2,323,376 shares
Largest sells
Since Q3 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Boeing Co~$854.8MSold out · 4.5% → 0.0%−2,246,766 shares
- Microsoft~$719.9MCut · 4.3% → 1.0%−4,565,153 shares
- Illumina Inc~$503.7MCut · 3.1% → 0.6%−1,518,298 shares
- Alibaba~$398.0MCut · 1.9% → 0.3%−1,876,330 shares
- United Technologies Corp~$273.3MSold out · 1.4% → 0.0%−2,001,875 shares
- Netflix~$259.5MCut · 6.0% → 5.4%−801,931 shares
- Gardner Denver Hldgs Inc~$250.3MCut · 1.2% → 0.2%−6,822,706 shares
- Anthem Inc~$237.8MCut · 4.8% → 4.4%−787,206 shares
- Jd Com Inc~$164.8MCut · 4.0% → 3.7%−4,678,603 shares
- Biomarin Pharmaceutical Inc~$121.4MCut · 1.1% → 0.6%−1,436,365 shares
Holdings
As of Dec 31, 2019. Changes are in shares against Sep 30, 2019, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AmazonCOM · shares −1.6% · price +6.4% | 7.7% | $1.64B | +$99.6M | ||||||||
| MetaCL A · shares +2.0% · price +15.3% | 6.1% | $1.31B | +$169.4M | ||||||||
| Adaptive Biotechnologies CorCOM · shares 0% · price −3.2% | 5.4% | $1.15B | −$37.6M | ||||||||
| NetflixCOM · shares −19% · price +20.9% | 5.4% | $1.14B | +$197.7M | ||||||||
| UberCOM · shares +163% · price −2.4% | 5.3% | $1.13B | −$10.6M | ||||||||
| Bridgebio Pharma IncCOM · shares 0% · price +63.3% | 4.4% | $933.1M | +$361.5M | ||||||||
| Anthem IncCOM · shares −20% · price +25.8% | 4.4% | $932.1M | +$191.1M | ||||||||
| Boston Scientific CorpCOM · shares +78% · price +11.1% | 3.9% | $836.2M | +$47.2M | ||||||||
| Monster Beverage Corp NewCOM · shares +23% · price +9.5% | 3.9% | $822.6M | +$57.8M | ||||||||
| Jd Com IncSPON ADR CL A · shares −17% · price +24.9% | 3.7% | $783.0M | +$156.0M | ||||||||
| ServiceNowCOM · shares +56% · price +11.2% | 3.6% | $777.4M | +$50.4M | ||||||||
| SalesforceCOM · shares −11% · price +9.6% | 3.3% | $710.4M | +$62.0M | ||||||||
| Centene Corp DelCOM · shares −12% · price +45.3% | 3.2% | $685.7M | +$213.9M | ||||||||
| BlockCL A · shares +0.1% · price +1.0% | 2.9% | $628.4M | +$6.1M | ||||||||
| Fortive CorpCOM · shares +48% · price +11.4% | 2.6% | $547.2M | +$37.9M | ||||||||
| Lowes Cos IncCOM · shares −9.2% · price +8.9% | 2.5% | $529.9M | +$43.4M | ||||||||
| MercadoLibreCOM · shares −12% · price +3.8% | 1.9% | $404.2M | +$14.6M | ||||||||
| Liberty Media Corp DelawareCOM SER C FRMLA · shares −14% · price +10.5% | 1.9% | $396.6M | +$37.8M | ||||||||
| Metlife IncCOM · shares New | 1.6% | $342.7M | — | ||||||||
| Molina HealthcareCOM · shares +57% · price +23.7% | 1.5% | $313.7M | +$38.2M | ||||||||
| Guardant Health IncCOM · shares +33% · price +22.4% | 1.4% | $299.6M | +$41.1M | ||||||||
| Unitedhealth Group IncCOM · shares New | 1.3% | $281.6M | — | ||||||||
| Booking Hldgs IncCOM · shares New | 1.2% | $262.2M | — | ||||||||
| Assurant IncCOM · shares +32% · price +4.2% | 1.1% | $244.0M | +$7.4M | ||||||||
| Activision Blizzard IncCOM · shares +421% · price +12.3% | 1.1% | $239.1M | +$5.0M | ||||||||
| Total · 66 positions | 100% | $21.35B | +$2.07B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2019 to Q4 2019: 48 stocks held throughout, up $2.07B (+14.2%).
- Bridgebio Pharma Inc+$361.5M+63%
- Centene Corp Del+$213.9M+45%
- Netflix+$197.7M+21%
- Anthem Inc+$191.1M+26%
- Meta+$169.4M+15%
- Middleby Corp−$8.2M−6%
- Uber−$10.6M−2%
- Adaptive Biotechnologies Cor−$37.6M−3%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $35.08B−2% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $35.75B−5% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $37.68B−2% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $38.50B+11% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $34.59B+10% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $31.48B+2% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $30.90B+13% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $27.44B+5% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $26.02B−3% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $26.86B−2% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $27.30B+11% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $24.64B+1% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $24.43B+15% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $21.31B+7% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $19.98B−8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $21.66B−1% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $21.86B−12% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $24.74B−29% | SEC ↗ |
| Q4 2021 | May 16, 2022 (amended) | $34.71B−5% | SEC ↗ |
| Q3 2021 | May 16, 2022 (amended) | $36.46B+11% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $32.98B−2% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $33.58B−8% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $36.37B+31% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $27.68B+20% | SEC ↗ |
| Q2 2020 | Aug 7, 2020 | $23.14B+20% | SEC ↗ |
| Q1 2020 | May 13, 2020 | $19.21B−10% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $21.35B+11% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $19.20B−14% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $22.29B+28% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $17.44B−1% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $17.57B−3% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $18.06B+3% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $17.47B+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $16.61B+2% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $16.26B+5% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $15.44B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $14.85B−34% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $22.64B+3% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $22.01B−5% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $23.18B−2% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $23.54B+4% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $22.72B | SEC ↗ |